Individual Stock News:
1. Country Garden (02007.HK): Plans to issue 136 million working fee shares in connection with a proposed restructuring.
2. Hengrui Medicine (01276.HK): Its injectable leuprorelin acetate microspheres have been approved for clinical trials.
3. Biren Technology (06082.HK): Plans to issue over 247 million shares in its Hong Kong IPO, with a maximum price of HK$19.6.
4. Rongda Technology (09881.HK): Plans to acquire all issued share capital of Shenzhen Yanke Digital for no more than RMB 65 million.
5. Joyson Electronics (00699.HK): Reached a strategic cooperation agreement with Sinian Intelligent Driving to jointly expand L4 commercial applications and embody intelligence technology.
6. Capital Venture Capital (02324.HK): Issued a profit warning: Expected annual net profit of approximately HK$115 million to HK$140 million, turning from a loss to a profit year-on-year.
7. Tianqi Lithium (09696.HK): Talison's Phase III chemical-grade lithium concentrate expansion project has been completed and officially put into trial operation.
8. Sichuan-Chengdu Expressway (00107.HK): A subsidiary plans to acquire an 85% stake in Hubei Jingyi Expressway Co., Ltd. for RMB 2.409 billion.
9. China Nonferrous Metal Mining (01258.HK) further acquired a 55% stake in Kazakhstan's SM Minerals, increasing its shareholding to 70%.
10. SF Holding (06936.HK): In November, the combined revenue from its express delivery, supply chain, and international businesses reached RMB 27.173 billion, a year-on-year increase of 7.85%.
11. Fosun Pharma (02696.HK): The Phase 1 clinical trial application for HLX18, a biosimilar of nivolumab, for the treatment of various solid tumors, was approved by the U.S. Food and Drug Administration.
